News

Update on NAPRA’s Model Documents for Pharmacy Regulatory Authority Use on Non-sterile and Sterile Compounding Standards

Update

The National Association of Pharmacy Regulatory Authorities (NAPRA) develops key national model documents that its Members, the pharmacy regulatory authorities (PRAs) across Canada, can use as desired. Having a national model document serves as a foundation for provincial/territorial requirements to help align practice and regulation across the country. NAPRA model documents for PRA use can be used as seen fit by the PRA in each province or territory, based on the needs in that jurisdiction.

In 2024, NAPRA began a review and update of its suite of model documents on standards of practice for pharmacy compounding. The goal of the project was to update the documents to better align with the outcomes-based approach taken for other NAPRA model documents, update the content based on current evidence-informed references, address any issues/concerns with the current documents, and ensure the documents reflect current and anticipated future pharmacy practice.

As part of the document development process, NAPRA held a public consultation on the draft documents from January 13, 2026, to March 15, 2026. NAPRA would like to thank all of the individuals and organizations who took the time to review the documents and provided valuable feedback. The working group for this project reviewed all feedback, considered the differing and conflicting perspectives, and made the appropriate changes to the document.

The documents have now been accepted by the NAPRA Board and NAPRA will begin the publishing process. Notice of publication will be posted on the NAPRA News page when available.

It is very important to note that since the NAPRA documents serve as a model that can be used as desired by the PRAs, there may be slight differences in how each province or territory decides to use the documents to create provincial/territorial requirements. The PRAs may adapt or adopt NAPRA’s example model documents, or may choose to create their own documents, as required to meet the needs in their jurisdiction.

Therefore, even once the new NAPRA documents are published, this does not mean that they are in effect. It will be important to consult the PRA in the relevant jurisdiction(s) to find out if and how the national model documents might be used to update provincial/territorial compounding standards, and what the implementation timelines will be for any changes in the relevant jurisdiction(s).

It is the responsibility of pharmacy professionals to review the requirements in the jurisdiction(s) in which they are regulated and follow the requirements set out by the PRA in those jurisdictions, which may differ from NAPRA’s example model documents.

Subscribe to updates from NAPRA

Receive NAPRA updates of interest directly to your inbox: general NAPRA news, NDS updates and/or updates on practice resources.